Literature DB >> 22583192

Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps.

E Pace1, V Scafidi, D Di Bona, L Siena, G Chiappara, M Ferraro, S La Grutta, S Gallina, R Speciale, A Ballacchino, C Bachert, J Bousquet, M Gjomarkaj.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is an inflammation of the nose and of the paranasal sinuses. The involvement of the respiratory epithelium in the mechanisms of CRS is poorly understood. AIMS: Among proteins expressed by nasal epithelial cells in CRS, IL-19 may have key functions. We here aimed to determine the expression and regulation of IL-19.
METHODS: Nasal biopsies from normal subjects (n = 12), subjects with CRS but without nasal polyps (NP) (CRSsNP, n = 12) and with CRS with NP (CRSwNP, n = 15) were collected. Human Asthma Gene Array and real-time PCR were used to evaluate gene expression, western blot analysis and immunohistochemistry for protein expression. Results for IL-19 were confirmed by real-time PCR. The constitutive and stimulated (LPS, TGF β) expression of IL-19 and cell proliferation were evaluated in a nasal epithelial cell line (RPMI 2650).
RESULTS: Human Asthma Gene Array showed an increased IL-19 gene expression in NP from patients with CRS in comparison with normal subjects. Real-time PCR confirmed the IL-19 mRNA up-regulation in patients with CRSwNP and showed an up-regulation of IL-19, at lower extent, in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) in comparison with normal subjects. Western blot analysis confirmed that IL-19 is increased also at protein level in patients with CRSwNP in comparison with normal subjects. In NP, IL-19 is highly expressed in the metaplastic nasal epithelium when compared to normal or hyperplastic epithelium. LPS stimulation increased IL-19 expression, and recombinant IL-19 increased cell proliferation in nasal epithelial cells.
CONCLUSIONS: IL-19 is overexpressed in the epithelium in CRSwNP and increases epithelial cell proliferation.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22583192     DOI: 10.1111/j.1398-9995.2012.02842.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  14 in total

1.  Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp.

Authors:  Murat Dogan; Mustafa Sahin; Cigdem Yenisey
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-19       Impact factor: 2.503

2.  Interleukin-19 Promotes Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy.

Authors:  Jingling Zou; Wei Tan; Bingyan Li; Zicong Wang; Yun Li; Jun Zeng; Bing Jiang; Shigeo Yoshida; Yedi Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

Review 3.  Gene expression signatures: a new approach to understanding the pathophysiology of chronic rhinosinusitis.

Authors:  Chunwei Li; Li Shi; Yan Yan; Bruce R Gordon; William M Gordon; De-Yun Wang
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

4.  Comparative cytoprotective effects of carbocysteine and fluticasone propionate in cigarette smoke extract-stimulated bronchial epithelial cells.

Authors:  Elisabetta Pace; Maria Ferraro; Serena Di Vincenzo; Chiara Cipollina; Stefania Gerbino; Diego Cigna; Valentina Caputo; Rossella Balsamo; Luigi Lanata; Mark Gjomarkaj
Journal:  Cell Stress Chaperones       Date:  2013-04-12       Impact factor: 3.667

5.  Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.

Authors:  Lei Bao; Jaime B Alexander; Vivian Y Shi; Girish C Mohan; Lawrence S Chan
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

6.  Human parainfluenza virus type 3 (HPIV3) induces production of IFNγ and RANTES in human nasal epithelial cells (HNECs).

Authors:  Anna Lewandowska-Polak; Małgorzata Brauncajs; Edyta Paradowska; Marzanna Jarzębska; Marcin Kurowski; Sylwia Moskwa; Zbigniew J Leśnikowski; Marek L Kowalski
Journal:  J Inflamm (Lond)       Date:  2015-02-21       Impact factor: 4.981

7.  Interleukin-19 impairment in active Crohn's disease patients.

Authors:  Elisabet Cantó; Esther Garcia Planella; Carlos Zamora-Atenza; Juan Camilo Nieto; Jordi Gordillo; Ma Angels Ortiz; Isidoro Metón; Elena Serrano; Esteban Vegas; Orlando García-Bosch; Cándido Juárez; Sílvia Vidal
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

8.  Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells.

Authors:  Andreina Bruno; Stefania Gerbino; Maria Ferraro; Liboria Siena; Angela Bonura; Paolo Colombo; Stefania La Grutta; Salvatore Gallina; Antonella Ballacchino; Marco Giammanco; Mark Gjomarkaj; Elisabetta Pace
Journal:  Mol Cell Biochem       Date:  2014-07-29       Impact factor: 3.396

9.  Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach.

Authors:  Giusy Daniela Albano; Caterina Di Sano; Anna Bonanno; Loredana Riccobono; Rosalia Gagliardo; Pascal Chanez; Mark Gjomarkaj; Angela Marina Montalbano; Giulia Anzalone; Stefania La Grutta; Fabio Luigi Massimo Ricciardolo; Mirella Profita
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  Association of BCL2 polymorphisms and the IL19 single nucleotide polymorphism rs2243188 with systemic lupus erythematosus.

Authors:  Weijie Wang; Xinchang Wang; Kepeng Yang; Yongsheng Fan
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.